Medical research

Using Epo to treat COVID-19

Erythropoietin (Epo) is actually a medication for anemia. According to researchers at the Max Planck Institute of Experimental Medicine in Göttingen, the doping agent Epo could also be effective against COVID-19. The growth ...

Diseases, Conditions, Syndromes

COVID-19 fattens up our body's cells to fuel its viral takeover

The virus that causes COVID-19 undertakes a massive takeover of the body's fat-processing system, creating cellular storehouses of fat that empower the virus to hijack the body's molecular machinery and cause disease.

page 1 from 14